Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
22.40
+0.37 (1.68%)
Nov 5, 2024, 4:00 PM EST - Market closed
Jasper Therapeutics Market Cap
Jasper Therapeutics has a market cap or net worth of $338.36 million as of November 5, 2024. Its market cap has increased by 356.62% in one year.
Market Cap
338.36M
Enterprise Value
233.86M
1-Year Change
356.62%
Ranking
Category
Stock Price
$22.40
Market Cap Chart
Since November 20, 2019, Jasper Therapeutics's market cap has increased from $125.00M to $338.36M, an increase of 170.69%. That is a compound annual growth rate of 22.23%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 4, 2024 | 332.80M | 278.18% |
Dec 29, 2023 | 88.00M | 380.87% |
Dec 30, 2022 | 18.30M | -93.84% |
Dec 31, 2021 | 297.10M | 137.49% |
Dec 31, 2020 | 125.10M | -0.64% |
Dec 31, 2019 | 125.90M | 0.72% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Nautilus Biotechnology | 327.72M |
Biomea Fusion | 327.60M |
CVRx, Inc. | 325.13M |
COMPASS Pathways | 324.84M |
iTeos Therapeutics | 321.76M |
Jin Medical International | 320.92M |
Aldeyra Therapeutics | 318.50M |
Eledon Pharmaceuticals | 316.62M |